Journal article

Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Cobbold, S., & Li, X. (2012). Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers? Frontiers in Immunology, 3(OCT), 317.

MLA Style

Cobbold, S., and X. Li. “Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What Are the Barriers?” Frontiers in Immunology, vol. 3, no. OCT, 2012, p. 317.

Chicago Style

Cobbold, S, and X Li. 2012. “Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What Are the Barriers?” Frontiers in Immunology 3 (OCT): 317.
Share
Print

Access Document

Publisher copy:: 10.3389/fimmu.2012.00317

Authors

+ Cobbold, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Pathology Dunn School
Role:: Author

+ Li, X More by this author

Role:: Author

Journal:: Frontiers in immunology More from this journal
Volume:: 3
Issue:: OCT
Pages:: 317
Publication date:: 2012-01-01
DOI:: 10.3389/fimmu.2012.00317
EISSN:: 1664-3224

Language:: English
Pubs id:: pubs:356161
UUID:: uuid:bd4baddd-cb15-4d39-bed6-d590f0bbceb4
Local pid:: pubs:356161
Source identifiers:: 356161
Deposit date:: 2013-11-17

Terms of use

Copyright date:: 2012

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP